These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24244263)

  • 1. A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis.
    Kumar A; Casey A; Odingo J; Kesicki EA; Abrahams G; Vieth M; Masquelin T; Mizrahi V; Hipskind PA; Sherman DR; Parish T
    PLoS One; 2013; 8(11):e72786. PubMed ID: 24244263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
    White EL; Southworth K; Ross L; Cooley S; Gill RB; Sosa MI; Manouvakhova A; Rasmussen L; Goulding C; Eisenberg D; Fletcher TM
    J Biomol Screen; 2007 Feb; 12(1):100-5. PubMed ID: 17175524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
    Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
    ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.
    Xu Z; Yin W; Martinelli LK; Evans J; Chen J; Yu Y; Wilson DJ; Mizrahi V; Qiao C; Aldrich CC
    Bioorg Med Chem; 2014 Mar; 22(5):1726-35. PubMed ID: 24507827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis.
    Evans JC; Trujillo C; Wang Z; Eoh H; Ehrt S; Schnappinger D; Boshoff HI; Rhee KY; Barry CE; Mizrahi V
    ACS Infect Dis; 2016 Dec; 2(12):958-968. PubMed ID: 27676316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.
    Ciulli A; Scott DE; Ando M; Reyes F; Saldanha SA; Tuck KL; Chirgadze DY; Blundell TL; Abell C
    Chembiochem; 2008 Nov; 9(16):2606-11. PubMed ID: 18821554
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase.
    Hung AW; Silvestre HL; Wen S; Ciulli A; Blundell TL; Abell C
    Angew Chem Int Ed Engl; 2009; 48(45):8452-6. PubMed ID: 19780086
    [No Abstract]   [Full Text] [Related]  

  • 10. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening.
    Abrahams GL; Kumar A; Savvi S; Hung AW; Wen S; Abell C; Barry CE; Sherman DR; Boshoff HI; Mizrahi V
    Chem Biol; 2012 Jul; 19(7):844-54. PubMed ID: 22840772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis.
    Ntie-Kang F; Kannan S; Wichapong K; Owono Owono LC; Sippl W; Megnassan E
    Mol Biosyst; 2014 Feb; 10(2):223-39. PubMed ID: 24240974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase.
    Zheng R; Blanchard JS
    Biochemistry; 2001 Oct; 40(43):12904-12. PubMed ID: 11669627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.
    Hung AW; Silvestre HL; Wen S; George GP; Boland J; Blundell TL; Ciulli A; Abell C
    ChemMedChem; 2016 Jan; 11(1):38-42. PubMed ID: 26486566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of NTF1836 as an inhibitor of the mycothiol biosynthetic enzyme MshC in growing and non-replicating Mycobacterium tuberculosis.
    Newton GL; Buchmeier N; La Clair JJ; Fahey RC
    Bioorg Med Chem; 2011 Jul; 19(13):3956-64. PubMed ID: 21665483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.
    Guzman JD; Gupta A; Evangelopoulos D; Basavannacharya C; Pabon LC; Plazas EA; Muñoz DR; Delgado WA; Cuca LE; Ribon W; Gibbons S; Bhakta S
    J Antimicrob Chemother; 2010 Oct; 65(10):2101-7. PubMed ID: 20719764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis.
    Kurosu M; Crick DC
    Med Chem; 2009 Mar; 5(2):197-207. PubMed ID: 19275719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.